$60.02
1.121.90%
At close: -
$59.93
-0.09-0.15%
After Hours: 6:54 PM EDT
Bristol-Myers Squibb reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Bristol-Myers Squibb using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
BMY | Bristol-Myers Squibb | -$4.40 | $1.83 | — | — | $11.87B | $11.67B | — | — | 04/24/2025 | Get Alert |
BMY | Bristol-Myers Squibb | $1.70 | $1.47 | $1.67 | 13.61% | $11.48B | $11.56B | $12.34B | 6.76% | 02/06/2025 | Get Alert |
BMY | Bristol-Myers Squibb | $2.00 | $1.49 | $1.80 | 20.81% | $10.97B | $11.28B | $11.89B | 5.43% | 10/31/2024 | Get Alert |
BMY | Bristol-Myers Squibb | $1.75 | $1.63 | $2.07 | 26.99% | $11.23B | $11.55B | $12.20B | 5.64% | 07/26/2024 | Get Alert |
BMY | Bristol-Myers Squibb | $2.05 | -$4.44 | -$4.40 | 0.90% | $11.34B | $11.46B | $11.87B | 3.53% | 04/25/2024 | Get Alert |
BMY | Bristol-Myers Squibb | $1.82 | $1.53 | $1.70 | 11.11% | $11.41B | $11.19B | $11.48B | 2.55% | 02/02/2024 | Get Alert |
BMY | Bristol-Myers Squibb | $1.99 | $1.76 | $2.00 | 13.64% | $11.22B | $10.97B | $10.97B | -0.04% | 10/26/2023 | Get Alert |
BMY | Bristol-Myers Squibb | $1.93 | $1.98 | $1.75 | -11.62% | $11.89B | $11.81B | $11.23B | -4.94% | 07/27/2023 | Get Alert |
BMY | Bristol-Myers Squibb | $1.96 | $1.97 | $2.05 | 4.06% | $11.65B | $11.49B | $11.34B | -1.33% | 04/27/2023 | Get Alert |
BMY | Bristol-Myers Squibb | $1.83 | $1.72 | $1.82 | 5.81% | $11.98B | $11.20B | $11.41B | 1.84% | 02/02/2023 | Get Alert |
BMY | Bristol-Myers Squibb | $2.00 | $1.83 | $1.99 | 8.74% | $11.62B | $11.19B | $11.22B | 0.25% | 10/25/2022 | Get Alert |
BMY | Bristol-Myers Squibb | $1.93 | $1.82 | $1.93 | 6.04% | $11.70B | $11.45B | $11.89B | 3.82% | 07/27/2022 | Get Alert |
BMY | Bristol-Myers Squibb | $1.74 | $1.91 | $1.96 | 2.62% | $11.07B | $11.36B | $11.65B | 2.54% | 04/29/2022 | Get Alert |
BMY | Bristol-Myers Squibb | $1.46 | $1.80 | $1.83 | 1.67% | $11.07B | $12.08B | $11.98B | -0.79% | 02/04/2022 | Get Alert |
BMY | Bristol-Myers Squibb | $1.63 | $1.92 | $2.00 | 4.17% | $10.54B | $11.58B | $11.62B | 0.38% | 10/27/2021 | Get Alert |
BMY | Bristol-Myers Squibb | $1.63 | $1.91 | $1.93 | 1.05% | $10.13B | $11.33B | $11.70B | 3.29% | 07/28/2021 | Get Alert |
BMY | Bristol-Myers Squibb | $1.72 | $1.82 | $1.74 | -4.40% | $10.78B | $11.11B | $11.07B | -0.33% | 04/29/2021 | Get Alert |
BMY | Bristol-Myers Squibb | $1.22 | $1.41 | $1.46 | 3.55% | $7.95B | $10.73B | $11.07B | 3.15% | 02/04/2021 | Get Alert |
BMY | Bristol-Myers Squibb | $1.17 | $1.49 | $1.63 | 9.40% | $6.01B | $10.33B | $10.54B | 2.03% | 11/05/2020 | Get Alert |
BMY | Bristol-Myers Squibb | $1.18 | $1.48 | $1.63 | 10.14% | $6.27B | $9.97B | $10.13B | 1.59% | 08/06/2020 | Get Alert |
BMY | Bristol-Myers Squibb | $1.10 | $1.49 | $1.72 | 15.44% | $5.92B | $10.02B | $10.78B | 7.59% | 05/07/2020 | Get Alert |
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-06 | $1.67 | $1.47 | 13.6 % |
Q3 | 2024-10-31 | $1.80 | $1.49 | 20.8 % |
Q2 | 2024-07-26 | $2.07 | $1.63 | 27.0 % |
Q1 | 2024-04-25 | $-4.40 | $-4.44 | 0.90 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-06 | $12.34B | $11.56B | 6.76 % |
Q3 | 2024-10-31 | $11.89B | $11.28B | 5.43 % |
Q2 | 2024-07-26 | $12.20B | $11.55B | 5.64 % |
Q1 | 2024-04-25 | $11.87B | $11.46B | 3.53 % |
Bristol-Myers Squibb (BMY) is scheduled to report earnings on April 24, 2025. The last reported earnings were for reported on February 6, 2025 for Q4.
The Actual EPS was $1.67, which beat the estimate of $1.47.
The Actual Revenue was $12.3B, which beat the estimate of $11.6B.
Browse earnings estimates, EPS, and revenue on all stocks.